Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

Daily Archives: June 3, 2019

Top 20 Shareholders, 31 May 2019

News & Announcements 2019, Top 20 ShareholdersBy Richard Mollard June 3, 2019

Top_Holders_Report (22)

Recent Articles

PAA Research Report May 2020
May 28, 2020
12 May, Phase II Trial – Successful Anti-Cancer Outcome
May 12, 2020
April 30, Top 20 Shareholders
April 30, 2020
30 April, Appendix 3G Notification of Issue, Conversion or Payment of Equity + Securities
April 30, 2020

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

PharmAust is a clinical-stage company developing novel targeted cancer therapeutics for both humans and animals. ASX: $PAA

Retweet on Twitter PharmAust Retweeted

Epichem @epichem·

We’re here to talk making #molecules for your needs – contact us now at https://bit.ly/2TpBdbo for a virtual tour of our working lab and how we can help create the right material for you

#chemistry #biotechnology #pharmaceuticals #LifeSciences #DrugDiscovery #science #research

Reply on Twitter 1265462765520633857 Retweet on Twitter 12654627655206338571 Like on Twitter 12654627655206338577 Twitter 1265462765520633857

Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions